Details
Title
Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells
Author
Gannon, Hugh S 1 ; Zou Tao 1 ; Kiessling, Michael K 2 ; Gao, Galen F 3
; Cai, Diana 1 ; Choi, Peter S 1 ; Ivan, Alexandru P 4
; Buchumenski Ilana 5 ; Berger, Ashton C 3 ; Goldstein, Jonathan T 3 ; Cherniack, Andrew D 1
; Vazquez Francisca 3
; Tsherniak Aviad 3
; Levanon, Erez Y 5
; Hahn, William C 6
; Meyerson, Matthew 7
1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
2 University of Zurich and University Hospital Zürich, Department of Gastroenterology and Hepatology, Zürich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); University Hospital Zurich, University of Zurich, Department of Medical Oncology and Hematology, Zurich, Switzerland (GRID:grid.412004.3) (ISNI:0000 0004 0478 9977)
3 Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
4 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
5 Bar-Ilan University, The Mina and Everard Goodman Faculty of Life Sciences, Ramat Gan, Israel (GRID:grid.22098.31) (ISNI:0000 0004 1937 0503)
6 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Harvard Medical School, Department of Medicine, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Dana-Farber Cancer Institute, Center for Cancer Genome Discovery, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
7 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Dana-Farber Cancer Institute, Center for Cancer Genome Discovery, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Harvard Medical School, Department of Pathology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
; Cai, Diana 1 ; Choi, Peter S 1 ; Ivan, Alexandru P 4
; Buchumenski Ilana 5 ; Berger, Ashton C 3 ; Goldstein, Jonathan T 3 ; Cherniack, Andrew D 1
; Vazquez Francisca 3
; Tsherniak Aviad 3
; Levanon, Erez Y 5
; Hahn, William C 6
; Meyerson, Matthew 7
1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
2 University of Zurich and University Hospital Zürich, Department of Gastroenterology and Hepatology, Zürich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); University Hospital Zurich, University of Zurich, Department of Medical Oncology and Hematology, Zurich, Switzerland (GRID:grid.412004.3) (ISNI:0000 0004 0478 9977)
3 Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
4 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
5 Bar-Ilan University, The Mina and Everard Goodman Faculty of Life Sciences, Ramat Gan, Israel (GRID:grid.22098.31) (ISNI:0000 0004 1937 0503)
6 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Harvard Medical School, Department of Medicine, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Dana-Farber Cancer Institute, Center for Cancer Genome Discovery, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
7 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Dana-Farber Cancer Institute, Center for Cancer Genome Discovery, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Harvard Medical School, Department of Pathology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
Publication year
2022
Publication date
2022
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2646021132
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.